Home
Modeling and Simulation to Select Oncology Dosages - Session 1
U.S. Food and Drug Administration
10 พ.ค. 2024
การดู 1,162 ครั้ง
Modeling and Simulation to Select Oncology Dosages - Session 2
185th Meeting of Vaccines and Related Biological Products Advisory Committee
Modeling and Simulation to Select Oncology Dosages - Session 3
FDA Oncology Drug Development Overview – Past to Present
Statistical Considerations for Premarketing Risk Assessment
Facilitating Generic Drug Product Development through Product-Specific Guidances
LACF and Acidified Foods Regulations and Requirements
Can Cardiac "Organ on a Chip" Technology Help Drug Toxicology Researchers? | Researching FDA
Episode 5 - On The Road with Jim Jones - April 2024
Osteoporosis: A Perspective for 2024
Can Cardiac "Organ on a Chip" Technology Help Drug Toxicology Researchers? (Full Video on Channel)
The Future of Clinical Trials, The Real Cost Campaign, and Sun Safety Tips | FDA In Your Day Ep. 5
Redesigned Pre-Submission Meetings in GDUFA III: Benefits for ANDA Submission and Approval
Waterproof Sunscreen? Sun Safety Tips from Episode 5 of FDA In Your Day | Full Video on Channel
REdI Annual Conference 2024: CBER (Biologics) Innovation in Medical Product Development (Day 1 of 2)
REdI Annual Conference 2024: CBER (Biologics) Innovation in Medical Product Development (Day 2 of 2)
REdI Annual Conference 2024: CDRH (Devices) Innovation in Medical Product Development (Day 1 of 2)
May 22, 2024 Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee
REdI Annual Conference 2024: CDER (Drugs) Innovation in Medical Product Development (Day 1 of 2)
REdI Annual Conference 2024: CDER (Drugs) Innovation in Medical Product Development (Day 2 of 2)